CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock	Common Stock SevenFive Farm	Common Stock TREES Englewood	Common Stock	Additional Paid-in Capital SevenFive Farm	Additional Paid-in Capital TREES Englewood	Additional Paid-in Capital 10% Warrants	Additional Paid-in Capital 15% Warrants	Additional Paid-in Capital	Accumulated Deficit	SevenFive Farm	TREES Englewood	10% Warrants	15% Warrants	Total
Balance at the beginning of the year at Dec. 31, 2019				$ 39,498					$ 61,468,034	$ (67,271,744)					$ (5,764,212)
Balance at the beginning of the year (in Shares) at Dec. 31, 2019				39,497,480
Warrants exercised				$ 200					172,041						172,241
Warrants exercised (in shares)				200,000
Common stock issued upon conversion of debt				$ 2,215					954,841						957,056
Common stock issued upon conversion of debt (in shares)				2,215,892
Beneficial conversion feature									233,500						233,500
Cashless exercise of warrants				$ 374					821,164						821,538
Cashless exercise of warrants (in shares)				373,340
Sale of stock, net of issuance costs				$ 7,575					3,092,425						3,100,000
Sale of stock, net of issuance costs (in shares)				7,574,745
Common stock issued for acquisition		$ 8,859			$ 1,894,522						$ 1,903,381
Common stock issued for acquisition (in shares)		8,859,117
Warrants issued with Notes								$ 835,499						$ 835,499
Stock-based compensation									1,347,688						1,347,688
Net loss										(4,529,546)					(4,529,546)
Balance at the end of the year at Sep. 30, 2020				$ 58,721					70,819,714	(71,801,290)					(922,855)
Balance at the end of the year(in Shares) at Sep. 30, 2020				58,720,574
Balance at the beginning of the year at Jun. 30, 2020				$ 51,189					67,406,256	(71,226,830)					(3,769,385)
Balance at the beginning of the year (in Shares) at Jun. 30, 2020				51,188,564
Sale of stock, net of issuance costs				$ 7,532					2,992,468						3,000,000
Sale of stock, net of issuance costs (in shares)				7,532,010
Stock options granted to employees and consultants									420,990						420,990
Net loss										(574,460)					(574,460)
Balance at the end of the year at Sep. 30, 2020				$ 58,721					70,819,714	(71,801,290)					(922,855)
Balance at the end of the year(in Shares) at Sep. 30, 2020				58,720,574
Balance at the beginning of the year at Dec. 31, 2020				$ 60,813					75,891,414	(74,951,436)					1,000,791
Balance at the beginning of the year (in Shares) at Dec. 31, 2020				60,813,673
Common stock issued to a consultant				$ 146					119,996						120,142
Common stock issued to a consultant (in Shares)				146,499
Common stock issued upon exercise of stock options				$ 367					194,267						$ 194,634
Common stock issued upon exercise of stock options (in shares)				366,760											366,760
Modification of warrants									233,374						$ 233,374
Modification of Options									21,525						21,525
Warrants issued							$ 1,239,300		106,554				$ 1,239,300		106,554
Beneficial conversion feature									1,110,039						1,110,039
Cashless exercise of warrants				$ 1,005					1,556,073						1,557,078
Cashless exercise of warrants (in shares)				1,006,623
Sale of stock, net of issuance costs	$ 1,073,446														1,073,446
Sale of stock, net of issuance costs (in shares)	1,180
Common stock issued for acquisition			$ 22,380			$ 10,384,464						$ 10,406,844
Common stock issued for acquisition (in shares)			22,380,310
Stock-based compensation									172,595						172,595
Net loss										(5,062,916)					(5,062,916)
Balance at the end of the year at Sep. 30, 2021	$ 1,073,446			$ 84,711					91,029,601	(80,014,352)					12,173,406
Balance at the end of the year(in Shares) at Sep. 30, 2021	1,180			84,713,865
Balance at the beginning of the year at Jun. 30, 2021				$ 62,264					80,140,373	(78,686,757)					1,515,880
Balance at the beginning of the year (in Shares) at Jun. 30, 2021				62,266,275
Common stock issued to a consultant				$ 34					20,108						20,142
Common stock issued to a consultant (in Shares)				34,140
Common stock issued upon exercise of stock options				$ 33					12,892						12,925
Common stock issued upon exercise of stock options (in shares)				33,140
Modification of warrants									233,374						233,374
Modification of Options									21,525						21,525
Warrants issued									106,554						106,554
Sale of stock, net of issuance costs	$ 1,073,446														1,073,446
Sale of stock, net of issuance costs (in shares)	1,180
Common stock issued for acquisition			$ 22,380			$ 10,384,464						$ 10,406,844
Common stock issued for acquisition (in shares)			22,380,310
Stock-based compensation									110,311						110,311
Net loss										(1,327,595)					(1,327,595)
Balance at the end of the year at Sep. 30, 2021	$ 1,073,446			$ 84,711					$ 91,029,601	$ (80,014,352)					$ 12,173,406
Balance at the end of the year(in Shares) at Sep. 30, 2021	1,180			84,713,865